Opioid use disorder

J Strang, ND Volkow, L Degenhardt… - Nature reviews Disease …, 2020 - nature.com
Opioid use disorder (OUD) is a chronic relapsing disorder that, whilst initially driven by
activation of brain reward neurocircuits, increasingly engages anti-reward neurocircuits that …

Advancing global health and strengthening the HIV response in the era of the Sustainable Development Goals: the International AIDS Society—Lancet Commission

LG Bekker, G Alleyne, S Baral, J Cepeda, D Daskalakis… - The Lancet, 2018 - thelancet.com
Executive summary Inspired by unprecedented improvements in human health and
development in recent decades, our world has embarked on a quest that only a generation …

Global patterns of opioid use and dependence: harms to populations, interventions, and future action

L Degenhardt, J Grebely, J Stone, M Hickman… - The Lancet, 2019 - thelancet.com
We summarise the evidence for medicinal uses of opioids, harms related to the extramedical
use of, and dependence on, these drugs, and a wide range of interventions used to address …

Responding to outbreaks of human immunodeficiency virus among persons who inject drugs—United States, 2016–2019: perspectives on recent experience and …

SB Lyss, K Buchacz, RP McClung… - The Journal of …, 2020 - academic.oup.com
In 2015, a large human immunodeficiency virus (HIV) outbreak occurred among persons
who inject drugs (PWID) in Indiana. During 2016–2019, additional outbreaks among PWID …

The opioid crisis and HIV in the USA: deadly synergies

SL Hodder, J Feinberg, SA Strathdee, S Shoptaw… - The Lancet, 2021 - thelancet.com
The opioid epidemic is one of the greatest public health problems that the USA faces. Opioid
overdose death rates have increased steadily for more than a decade and doubled in 2013 …

Women and barriers to harm reduction services: a literature review and initial findings from a qualitative study in Barcelona, Spain

S Shirley-Beavan, A Roig, N Burke-Shyne… - Harm Reduction …, 2020 - Springer
Background There are an estimated 3.2 million women who inject drugs worldwide,
constituting 20% of all people who inject drugs. The limited data that are available suggest …

Concurrent initiation of hepatitis C and opioid use disorder treatment in people who inject drugs

ES Rosenthal, R Silk, P Mathur, C Gross… - Clinical Infectious …, 2020 - academic.oup.com
Background People who inject drugs have a high prevalence of hepatitis C virus (HCV) and
significant disease associated with drug use; however, HCV treatment often occurs in …

[PDF][PDF] Key considerations for differentiated antiretroviral therapy delivery for specific populations: children, adolescents, pregnant and breastfeeding women and key …

World Health Organization - 2017 - apps.who.int
Third-party materials. If you wish to reuse material from this work that is attributed to a third
party, such as tables, figures or images, it is your responsibility to determine whether …

The WHO public health approach to HIV treatment and care: looking back and looking ahead

N Ford, A Ball, R Baggaley, M Vitoria… - The Lancet Infectious …, 2018 - thelancet.com
In 2006, WHO set forth its vision for a public health approach to delivering antiretroviral
therapy. This approach has been broadly adopted in resource-poor settings and has …

The impact of buprenorphine and methadone on mortality: a primary care cohort study in the United Kingdom

M Hickman, C Steer, K Tilling, AG Lim, J Marsden… - …, 2018 - Wiley Online Library
Aims To estimate whether opioid substitution treatment (OST) with buprenorphine or
methadone is associated with a greater reduction in the risk of all‐cause mortality (ACM) …